Abstract:
Conclusion: This study showed that anti-HCV seroprevalence increased with advancing age. Based on the results of this study, since there is possibility of risky transfusions made before the era of routine screening tests before transfusion, and risk of viral transmission at procedures without aseptic conditions, onetime anti-HCV testing may be offered for screening purposes in individuals over the age of 50 years.